Recent Advances in Pharmacotherapies for the Externalizing Disorders.
- 1 January 2005
- journal article
- Published by American Psychological Association (APA) in School Psychology Quarterly
- Vol. 20 (2), 118-134
- https://doi.org/10.1521/scpq.20.2.118.66515
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorderExpert Opinion on Pharmacotherapy, 2003
- Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled StudyAmerican Journal of Psychiatry, 2002
- Pediatric psychopharmacology: A review of new developments and recent research.Professional Psychology: Research and Practice, 2002
- Recent developments in the pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD).Professional Psychology: Research and Practice, 2002
- Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response StudyPediatrics, 2001
- Mecamylamine: new therapeutic uses and toxicity/risk profileClinical Therapeutics, 2001
- In search of how people change: Applications to addictive behaviors.American Psychologist, 1992
- Stimulant Medication and the Treatment of Aggression in Children With Attentional DeficitsJournal of Clinical Child Psychology, 1991
- Anitdepressants in the Treatment of Child and Adolescent PsychopathologyJournal of Clinical Child Psychology, 1991
- Treatment of antisocial behavior in children: Current status and future directions.Psychological Bulletin, 1987